“…The cytokine can have both protective and pathogenic effects in different infection and inflammation models and organ systems (Onishi and Gaffen, 2010). In the intestinal tract, IL-17A is required for protective immunity against Helicobacter pylori (Algood, et al, 2009), Citrobacter rodentium (Ishigame, et al, 2009), Salmonella enterica serovar Typhimurium (Mayuzumi, et al, 2010; Raffatellu, et al, 2008), and enteroaggregative Escherichia coli (Philipson, et al, 2013), indicating that IL-17A is an important regulator of mucosal immune defenses associated with mucosal inflammation. Although Giardia infection is typically devoid of acute inflammatory events (Oberhuber, et al, 1997), a recent study found that IL-17A contributes to clearance of the murine pathogen Giardia muris (Dreesen, et al, 2014).…”